Colomer Bosch, Ramon ramon.colomer@uam.es

Publications

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

  • Colomer, R
  • Miranda, J
  • Romero-Laorden, N
  • Hornedo, J
  • González-Cortijo, L
  • Mouron, S
  • Bueno, MJ
  • Mondéjar, R
  • Quintela-Fandino, M
... View more Collapse

Eclinicalmedicine - 1/6/2023

10.1016/j.eclinm.2023.102029 View at source

  • ISSN 25895370

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer

  • Jimeno R, Mouron S, Salgado R, Loi S, Pérez-Mies B, Sánchez-Bayona R, Manso L, Martínez M, Garrido-García A, Serrano-Pardo R, Colomer R, Quintela-Fandino M

Clinical & Translational Oncology (p. 1124-1131) - 1/4/2023

Editor: Springer Science and Business Media Deutschland GmbH

10.1007/s12094-022-03006-3 View at source

  • ISSN 1699048X
  • ISSN/ISBN 1699-3055

Distribution of PD-L1, TROP2 and HER2-"lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation

  • Bueno, MJ
  • Mouron, S
  • Caleiras, E
  • Martínez, M
  • Manso, L
  • Colomer, R
  • Quintela-Fandino, M
... View more Collapse

Clinical & Translational Oncology - 18/10/2023

10.1007/s12094-023-03329-9 View at source

  • ISSN 1699048X

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

  • Johnston, SRD
  • Toi, M
  • O'Shaughnessy, J
  • Rastogi, P
  • Campone, M
  • Neven, P
  • Huang, CS
  • Huober, J
  • Jaliffe, GG
  • Cicin, I
  • Tolaney, SM
  • Goetz, MP
  • Rugo, HS
  • Senkus, E
  • Testa, L
  • Del Mastro, L
  • Shimizu, C
  • Wei, R
  • Shahir, A
  • Munoz, M
  • San Antonio, B
  • AndrT, V
  • Harbeck, N
  • Martin, M
... View more Collapse

Lancet Oncology (p. 77-90) - 3/1/2023

10.1016/s1470-2045(22)00694-5 View at source

  • ISSN 14702045

Progress and oncological outcome of neoadjuvant therapy in breast cancer patients during a 10-year period

  • Ballesteros AI
  • López MP
  • Mondejar R
  • Pacheco-Barcia V
  • Donnay O
  • Hernández B
  • Romero-Laorden N
  • Doblado B
  • Álvarez López RM
  • Pérez-Fernández E
  • Colomer R
... View more Collapse

Revista De Senologia Y Patologia Mamaria (p. 167-174) - 1/7/2022

Editor: Elsevier Doyma

10.1016/j.senol.2021.09.002 View at source

  • ISSN 02141582
  • ISSN/ISBN 1578-1399

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC

  • Rogado, Jacobo
  • Pozo, Fernando
  • Troule, Kevin
  • Miguel Sanchez-Torres, Jose
  • Romero-Laorden, Nuria
  • Mondejar, Rebeca
  • Donnay, Olga
  • Ballesteros, Anabel
  • Pacheco-Barcia, Vilma
  • Aspa, Javier
  • Al-Shahrour, Fatima
  • Alfranca, Arantzazu
  • Colomer, Ramon
... View more Collapse

Cancers - 1/6/2022

Editor: MDPI

10.3390/cancers14122898 View at source

  • ISSN 20726694
  • ISSN/ISBN 2072-6694

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer

  • Dang, Chau
  • Ewer, Michael S.
  • Delaloge, Suzette
  • Ferrero, Jean-Marc
  • Colomer, Ramon
  • de la Cruz-Merino, Luis
  • Werner, Theresa L.
  • Dadswell, Katherine
  • Verrill, Mark
  • Eiger, Daniel
  • Sarkar, Sriparna
  • de Haas, Sanne Lysbet
  • Restuccia, Eleonora
  • Swain, Sandra M.;
... View more Collapse

Cancers - 1/6/2022

10.3390/cancers14112596 View at source

  • ISSN 20726694

The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair

  • Pacheco-Barcia, Vilma
  • Munoz, Andres
  • Castro, Elena
  • Ballesteros, Ana Isabel
  • Marquina, Gloria
  • Gonzalez-Diaz, Ivan
  • Colomer, Ramon
  • Romero-Laorden, Nuria;
... View more Collapse

Cancers - 1/6/2022

Editor: MDPI

10.3390/cancers14122950 View at source

  • ISSN 20726694
  • ISSN/ISBN 2072-6694

Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

  • Garcia-Alfonso, P
  • Saiz-Rodriguez, M
  • Mondejar, R
  • Salazar, J
  • Paez, D
  • Borobia, A M
  • Safont, M J
  • Garcia-Garcia, I
  • Colomer, R
  • Garcia-Gonzalez, X
  • Herrero, M J
  • Lopez-Fernandez, L A
  • Abad-Santos, F
... View more Collapse

Clinical & Translational Oncology (p. 483-494) - 1/3/2022

10.1007/s12094-021-02708-4 View at source

  • ISSN 1699048X

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A

  • Mouron S
  • Bueno MJ
  • Lluch A
  • Manso L
  • Calvo I
  • Cortes J
  • Garcia-Saenz JA
  • Gil-Gil M
  • Martinez-Janez N
  • Apala JV
  • Caleiras E
  • Ximénez-Embún P
  • Muñoz J
  • Gonzalez-Cortijo L
  • Murillo R
  • Sánchez-Bayona R
  • Cejalvo JM
  • Gómez-López G
  • Fustero-Torre C
  • Sabroso-Lasa S
  • Malats N
  • Martinez M
  • Moreno A
  • Megias D
  • Malumbres M
  • Colomer R
  • Quintela-Fandino M
... View more Collapse

Nature Communications - 1/12/2022

10.1038/s41467-022-35065-z View at source

  • ISSN 20411723

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …

  • Chau Dang
  • Michael S Ewer
  • Suzette Delaloge
  • Jean-Marc Ferrero
  • Mark Verrill
  • Ramon Colomer
  • Claudia Vieira
  • Luis de la Cruz Merino
  • Jennifer Lucas
  • Theresa L Werner
  • Hannah Douthwaite
  • Denise Bradley
  • Maeve Waldron-Lynch
  • Jennifer Eng-Wong
  • Sandra M Swain
... View more Collapse

1/1/2018

  • iMarina

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • MD Fenor De La Maza
  • V Pacheco-Barcia
  • JM Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondejar
  • O Donnay
  • B Obispo
  • R Colomer
  • JM Sanchez-Torres
... View more Collapse

1/1/2017

  • iMarina

Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study

  • J Albanell
  • E Ciruelos
  • R Colomer
  • J De la Haba
  • M Martin
  • De Salas-Cansado
  • B Munoz-Molina
  • C Tournier
  • P Thuresson
  • W Schleich
... View more Collapse

1/1/2015

  • iMarina

Tratado de oncología

  • Hernán Cortés-Funes
  • Ramón Colomer Bosch
  • Emilio Alba Conejo

1/1/2009

  • ISBN 9788492620166
  • iMarina

Medicina de precisión en oncología: Éxitos y perspectivas bioéticas

  • Ramón Colomer Bosch

Bioética Y Cáncer (p. 17-26) - 1/1/2020

  • iMarina

Fatty acid metabolism in cancer cell survival: A new anti-cancer target

  • Porta, Rut
  • Colomer, Ramon
  • Puig, Teresa;

Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011

  • iMarina

Factores pronósticos y predictivos

  • Alejandro Rojo
  • Juan Fernando García García
  • Lucía González Cortijo
  • J Hornedo Muguiro
  • Antonio González Martín
  • Gloria Ortega Pérez
  • Luis Cabañas
  • Ramón Colomer Bosch
... View more Collapse

Tratado De Cáncer De Mama (p. 13-24) - 1/1/2008

  • iMarina

Investigación clínica en el cáncer de mama

  • Agustí Barnadas i Molins
  • Ramón Colomer Bosch

Tratado De Cáncer De Mama (p. 131-143) - 1/1/2008

  • iMarina

Tratamiento hormonal del cáncer

  • Ramón Colomer Bosch
  • M L Amador
  • J González Cortijo
  • MV Tornamira

Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003

  • iMarina

Phase IB/II trial of palbociclib and binimetinib in advanced triple-negative breast cancer with hyperactivation of ERK and/or CDK4/6

  • Manso, Luis
  • Cortes, Alfonso
  • Cejalvo, Juan M.
  • Morales, Serafin
  • Saenz, Jose A. Garcia
  • Colomer, Ramon
  • Sanchez-Bayona, Rodrigo
  • Silva, Jorge
  • Guerra, Juan A.
  • Malon, Diego
  • Mouron, Silvana
  • Caleiras, Eduardo
  • Quintela-Fandino, Miguel;
... View more Collapse

Cancer Research - 15/2/2022

10.1158/1538-7445.sabcs21-ot2-19-08 View at source

  • ISSN 00085472

Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial

  • Dang, C.
  • Ewer, M. S.
  • Delaloge, S.
  • Ferrero, J-M.
  • Colomer, R.
  • de la Cruz Merino, L.
  • Dadswell, K.
  • Verrill, M.
  • Eiger, D.
  • Sarkar, S.
  • de Haas, S.
  • Restuccia, E.
  • Swain, S. M.;
... View more Collapse

Annals Of Oncology (p. S38-S39) - 1/5/2021

10.1016/j.annonc.2021.03.057 View at source

  • ISSN 09237534

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

  • Im, S-A.
  • Tan, A. R.
  • Mattar, A.
  • Colomer, R.
  • Stroyakovskii, D.
  • Nowecki, Z.
  • De Laurentiis, M.
  • Pierga, J-Y.
  • Jung, K. H.
  • Schem, C.
  • Aguila, C.
  • Crnjevic, T. Badovinac
  • Heeson, S.
  • Shivhare, M.
  • Alexandrou, A.
  • Restuccia, E.
  • Jackisch, C.;
... View more Collapse

Annals Of Oncology (p. S40-S41) - 1/5/2021

10.1016/j.annonc.2021.03.060 View at source

  • ISSN 09237534

Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy

  • Rogado, J.
  • Pozo, F.
  • Troule, K.
  • Sanchez-Torres, J. M.
  • Romero Laorden, N.
  • Mondejar Solis, R.
  • Donnay Candil, O.
  • Ballesteros Garcia, A. I.
  • Pacheco-Barcia, V.
  • Aspa, J.
  • Al-Shahrour, F.
  • Alfranca, A.
  • Colomer, R.;
... View more Collapse

Annals Of Oncology (p. S999-S1000) - 1/1/2021

10.1016/j.annonc.2021.08.1889 View at source

  • ISSN 09237534

Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)

  • Rogado Revuelta, Jacobo
  • Romero-Laorden, Nuria
  • Sanchez Torres, Jose Miguel
  • Pacheco-Barcia, Vilma
  • Ballesteros, Anabel
  • Maria Ramos-Levi, Ana
  • Arranz, Reyes
  • Lorenzo, Alicia
  • Gullon, Pedro
  • Garrido Garcia, Ana
  • Maria Serra, Jose
  • Donnay, Olga
  • Adrados, Magdalena
  • Costas, Pablo
  • Aspa, Javier
  • Alfranca, Arantza
  • Fenor De la Maza, Maria Dolores
  • Mondejar, Rebeca
  • Colomer, Ramon;
... View more Collapse

Journal Of Clinical Oncology - 1/1/2019

  • ISSN 0732183X
  • iMarina

CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN

  • Ciruelos, E.
  • Alba, E.
  • Lopez, R.
  • Lluch, A.
  • Martin, M.
  • Arroyo, I
  • Navarro, B.
  • Carcedo, D.
  • Colomer, R.
  • Albanell, J.;
... View more Collapse

Value In Health (p. S18-S18) - 1/1/2018

10.1016/j.jval.2018.09.102 View at source

  • ISSN 10983015

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE study

  • Dang, Chau
  • Ewer, Michael S.
  • Delaloge, Suzette
  • Ferrero, Jean-Marc
  • Verrill, Mark
  • Colomer, Ramon
  • Vieira, Claudia
  • de la Cruz-Merino, Luis
  • Lucas, Jennifer
  • Werner, Theresa L.
  • Douthwaite, Hannah
  • Bradley, Denise
  • Waldron-Lynch, Maeve
  • Eng-Wong, Jennifer
  • Swain, Sandra M.;
... View more Collapse

Cancer Research - 1/1/2018

  • ISSN 00085472
  • iMarina

Safety of self-expandable metal stents (SEMS) or emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab

  • Pacheco-Barcia, V.
  • Mondejar Solis, R.
  • Martinez Saez, O.
  • Longo Munoz, F.
  • Bermejo, E.
  • Moreno Monteagudo, J.
  • Marin, C.
  • Correa, A.
  • Maqueda, R.
  • Rogado, J.
  • Garcia de Paredes, A.
  • Rodriguez de Santiago, E.
  • Pachon Olmos, V.
  • Ferreiro Monteagudo, R.
  • Rodriguez Garrote, M.
  • Carrato, A.
  • Donnay, O.
  • Martin, E.
  • Santander, C.
  • Colomer, R.;
... View more Collapse

Annals Of Oncology - 1/1/2018

  • ISSN 09237534
  • iMarina

The impact of primary tumor location in patients with resected colorectal liver metastasis

  • Pacheco-Barcia, V.
  • Donnay, O.
  • Solis, R. Mondejar
  • Serrano, R.
  • Martin, E.
  • del Campo, L.
  • Rogado, J.
  • Vera, B.
  • Ballesteros, A.
  • Colomer, R.;
... View more Collapse

Annals Of Oncology - 1/1/2018

  • ISSN 09237534
  • iMarina

Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival

  • V Pacheco-Barcia
  • T France
  • G Zogopoulos
  • N Bouganim
  • O Donnay
  • T Alcindor
  • R Mondéjar Solís
  • K Guo
  • E Martin
  • R Colomer
  • J Asselah
... View more Collapse

Annals Of Oncology (p. mdy151. 163-mdy151. 163) - 1/1/2018

  • ISSN 09237534
  • iMarina

[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]

  • Sanchez-Munoz, A
  • Gravalos Castro, C
  • Colomer Bosch, R
  • Garcia Velasco, A
  • Garcia, J P
  • Cortes-Funes, H

Revista Clinica Espanola (p. 597-598) - 1/1/2003

10.1157/13053731

  • ISSN 15781860
  • iMarina

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

  • Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators

Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020

10.1200/jco.20.02514

  • ISSN 0732183X
  • iMarina

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer

  • Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R

Clinical Breast Cancer (p. 286-91) - 1/1/2003

10.3816/cbc.2003.n.034 View at source

  • ISSN 15268209

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

  • Gonzalez Baron, Manuel
  • Arranz, R
  • Garcia-Alfonso, P
  • Sobrino, P
  • Zamora, P
  • Carrion, R
  • Garcia-Larana, J
  • Perez, G
  • Lopez, J
  • Lavilla, E
  • Lozano, M
  • Rayon, C
  • Colomer, R
  • Baron, MG
  • Baron, M G
  • Flores, E
  • Perez-Manga, G
  • Fernandez-Ranada, JM
  • Fernandez-Ranada, J M
... View more Collapse

Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998

Editor: American Society of Clinical Oncology

10.1200/jco.1998.16.4.1538 View at source

  • ISSN 0732183X
  • ISSN/ISBN 0732-183X

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

  • Hitt, R
  • Paz-Ares, L
  • Hidalgo, M
  • Colomer, R
  • Brandariz, A
  • Pena, M
  • Alvarez-Vicent, J
  • Hornedo, J
  • Cortes-Funes, H;
... View more Collapse

Seminars In Oncology (p. S19-20) - 1/12/1997

  • ISSN 00937754
  • iMarina

Desestabilización estructural de la adicción a oncogenes en cáncer de mama mediante el bloqueo de la sintasa de ácidos grasos

  • Colomer Bosch, Ramon (Investigador principal (IP))

Period: 01-01-2012 - 31-12-2014

  • iMarina

Impacto de la implantación del tratamiento neoadyuvante del cáncer de mama en la práctica clínica habitual durante un periodo de diez años

  • Ramón Colomer Bosch (Director) Doctorando: Ana Isabel Ballesteros García

14/3/2023

  • iMarina

Predictores inmunológicos y clínicos de eficacia a tratamiento con anticuerpos monoclonales frente al receptor de muerte programada tipo 1 (anti PD-1) en cáncer no microcítico de pulmón

  • Ramón Colomer Bosch (Director)
  • Nuria Romero Laorden (Director) Doctorando: Jacobo Rogado Revuelta

6/3/2023

  • iMarina

Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas

  • Rebeca Mondéjar Solís (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia

28/1/2021

  • iMarina

Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís

1/1/2016

  • iMarina

El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Javier Abel Menéndez Menéndez (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo

1/1/2016

  • iMarina

Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín

1/1/2007

  • iMarina

Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia

1/1/2004

  • iMarina

Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo

1/1/2003

  • iMarina

Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz

1/1/2002

  • iMarina

Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez

1/1/2001

  • iMarina

This researcher has no patents or software licenses.

Last data update: 8/28/24 4:32 PM